#3 Flashcards
Which one of the following statements reflects the U.S. Preventive Services Task Force recommendation on screening for impaired visual acuity in older adults?
A. Screen all adults every one to two years starting at 65 years of age.
B. Screen high-risk groups starting at 65 years of age.
C. Do not screen because the harms outweigh the potential benefits.
D. There is insufficient evidence to assess the balance of benefits and harms.
D. There is insufficient evidence to assess the balance of benefits and harms.
A 68-year-old man with no history of visual problems is newly diagnosed with type 2 diabetes mellitus. When should he have a dilated eye examination?
A. Now, then at least annually.
B. Now, then every two years.
C. In five years, then annually.
D. As soon as he develops visual symptoms.
A. Now, then at least annually.
Which one of the following statements about tests and examinations before cataract surgery is correct?
A. Medical testing is not recommended.
B. Physical examination should be performed.
C. Physical examination and complete blood count should be performed.
D. Physical examination, complete blood count, and electrocardiography should be performed.
A. Medical testing is not recommended.
Which one of the following pairs of medications is approved by the U.S. Food and Drug Administration for the treatment of painful diabetic peripheral neuropathy?
A. Amitriptyline and topiramate (Topamax).
B. Gabapentin (Neurontin) and duloxetine (Cymbalta).
C. Pregabalin (Lyrica) and duloxetine.
D. Pregabalin and gabapentin.
C. Pregabalin (Lyrica) and duloxetine.
Which one of the following statements about the use of transcutaneous electrical nerve stimulation for the treatment of painful diabetic peripheral neuropathy is correct?
A. It is considered a third-line treatment.
B. It can be used at any time as an adjunct to other treatments.
C. High-quality randomized controlled trials have shown that it is less effective than electromagnetic field application.
D. Randomized controlled trials show no evidence of benefit.
B. It can be used at any time as an adjunct to other treatments.
Which one of the following statements about the diagnosis of premenstrual disorders is correct?
A. Symptoms must continue throughout the menstrual cycle.
B. Recording symptoms on the first day of menses using the Daily Record of Severity of Problems is an acceptable screening method.
C. The presence of physical symptoms effectively rules out premenstrual dysphoric disorder (PMDD).
D. Response to cognitive behavior therapy is sufficient for diagnosis.
B. Recording symptoms on the first day of menses using the Daily Record of Severity of Problems is an acceptable screening method.
Which one of the following medications is the preferred treatment for severe symptoms of premenstrual syndrome (PMS)?
A. Bupropion (Wellbutrin).
B. Selective serotonin reuptake inhibitors (SSRIs).
C. Gonadotropin-releasing hormone agonists.
D. Vitamin D supplements.
B. Selective serotonin reuptake inhibitors (SSRIs).
Which one of the following statements about the treatment of PMS and PMDD is correct?
A. Higher doses of SSRIs are needed to treat the physical symptoms of these disorders.
B. SSRIs need to be stopped during the luteal phase of the menstrual cycle to be effective.
C. The most effective complementary treatment is Chinese herbal medication.
D. High calcium intake tends to increase symptoms of depression and fatigue.
A. Higher doses of SSRIs are needed to treat the physical symptoms of these disorders.
Which one of the following statements about the use of acetaminophen for the treatment of pain in newborns is correct?
A. Oral acetaminophen (20 mg per kg) is less effective than oral glucose for the treatment of pain in newborns who are undergoing heel lance.
B. Acetaminophen suppositories (50 to 70 mg) do not decrease pain scores in infants born by assisted vaginal delivery who are subsequently exposed to heel lance.
C. The American Academy of Pediatrics recommends that acetaminophen not be used alone but may be an adjunctive therapy for severe pain and may be used after minor procedures.
D. All of the above.
D. All of the above.
Which one of the following statements about competitive athletes with cardiovascular abnormalities is correct?
A. Athletes with acute pericarditis can return to play 48 hours after initial symptoms.
B. Asymptomatic patients with hypertrophic cardiomyopathy genotype should not participate in competitive sports.
C. Patients with arrhythmogenic right ventricular cardiomyopathy may participate in most competitive sports.
D. In persons with suspected acute myocarditis, resting echocardiography, Holter monitoring for 24 hours, and exercise electrocardiography should be performed before a return to competitive sports is allowed.
D. In persons with suspected acute myocarditis, resting echocardiography, Holter monitoring for 24 hours, and exercise electrocardiography should be performed before a return to competitive sports is allowed.
